Influence of functional polymorphisms of the gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (45)
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
2000 • 2,358 citations
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 • 2,049 citations
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
2003 • 1,750 citations
Expression of a multidrug-resistance gene in human tumors and tissues.
1987 • 1,547 citations
Identification of functionally variant MDR1 alleles among European Americans and African Americans
2001 • 1,000 citations
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
2004 • 900 citations
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
1994 • 777 citations
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
2001 • 757 citations
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
1994 • 685 citations
Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.
1999 • 663 citations
Mechanism of inhibition of cell proliferation by Vinca alkaloids.
1991 • 534 citations
MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
2001 • 418 citations
MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.
2001 • 319 citations
Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene
2002 • 307 citations
Association of the Multidrug Resistance-1 Gene Single-Nucleotide Polymorphisms with the Tacrolimus Dose Requirements in Renal Transplant Recipients
2003 • 281 citations
Explaining Interindividual Variability of Docetaxel Pharmacokinetics and Pharmacodynamics in Asians Through Phenotyping and Genotyping Strategies
2002 • 269 citations
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein
2002 • 268 citations
Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
2003 • 248 citations
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
2002 • 247 citations
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs
2003 • 226 citations
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression
2002 • 204 citations
The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol
2002 • 201 citations
C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation
2002 • 194 citations
Digoxin pharmacokinetics and MDR1 genetic polymorphisms
2003 • 169 citations
Pharmacological insights from P-glycoprotein knockout mice.
1998 • 147 citations
Polymorphisms in the ABC drug transporter gene MDR1
2001 • 136 citations
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia
2003 • 133 citations
The pharmacokinetics of [3H]‐vincristine in man
1977 • 105 citations
Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.
2002 • 104 citations
Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro
1996 • 98 citations
Mdr1 Limits CYP3A Metabolism in Vivo
2000 • 90 citations
Cytochrome P450?inducing antiepileptics increase the clearance of vincristine in patients with brain tumors
1999 • 90 citations
Biliary excretion of vincristine
1978 • 83 citations
Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance.
2000 • 76 citations
Pharmacokinetics of Vincristine Monotherapy in Childhood Acute Lymphoblastic Leukemia
2002 • 71 citations
Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.
1999 • 70 citations
Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver
1992 • 70 citations
Vincristine disposition in children with acute lymphoblastic leukemia
1995 • 60 citations
Neurotoxicity of antineoplastic agents
1993 • 45 citations
Hyponatremia and syndrome of inappropriate anti‐diuretic hormone reported with the use of Vincristine®: an over‐representation of Asians?
2002 • 43 citations
Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats
1995 • 40 citations
Homozygous Disruption of the mdr1a P-glycoprotein Gene Affects Blood-Nerve Barrier Function in Mice Administered with Neurotoxic Drugs
2001 • 35 citations
Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction
1991 • 35 citations
P-glycoprotein expression in capillary endothelial cells of the 7th and 8th nerves of guinea pig in relation to blood–nerve barrier sites
1997 • 24 citations
An Automated Method for the Bioanalysis of Vincristine Suitable for Therapeutic Drug Monitoring and Pharmacokinetic Studies in Young Children
2001 • 19 citations